• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可改变的血管危险因素、脑白质病变与早期帕金森病患者的认知功能

Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.

机构信息

Department of Neurology, University of Pittsburgh, Pittsburgh, PA.

Department of Neurology, University of Pennsylvania, Philadelphia, PA.

出版信息

Eur J Neurol. 2019 Feb;26(2):246-e18. doi: 10.1111/ene.13797. Epub 2018 Oct 28.

DOI:10.1111/ene.13797
PMID:30169897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6329649/
Abstract

BACKGROUND AND PURPOSE

Dementia in Parkinson's disease (PD) is common and disabling. Identification of modifiable risk factors for it is essential. Vascular risk factors (VRFs) may be associated with cognitive decline in early PD. Biomarkers that serve as surrogates of the long-term effect of VRFs on PD are needed. To that end, we aimed to quantitate white matter hyperintensities (WMH) in early PD, measure associations with VRFs and examine relationships between WMH and longitudinal cognition.

METHODS

Participants in the Parkinson's Progression Markers Initiative study (141 patients with PD, 63 healthy controls) with adequate baseline structural brain magnetic resonance imaging data were included. Hypertension and diabetes history, and body mass index were combined to create a vascular risk score. WMH were quantitated via automated methods. Cognition was assessed annually with a comprehensive test battery.

RESULTS

In the PD group, vascular risk score was associated with WMH for total brain (β = 0.210; P = 0.021), total white matter (β = 0.214; P = 0.013), frontal (β = 0.220; P = 0.002) and temporal (β = 0.212; P = 0.002) regions. Annual rate of change in global cognition was greater in those with higher vascular risk score (β = -0.040; P = 0.007) and greater WMH (β = -0.029; P = 0.049). Higher temporal WMH burden was associated with great decline over time in verbal memory (β = -0.034; P = 0.031).

CONCLUSIONS

In early PD, modifiable VRFs are associated with WMH on brain magnetic resonance imaging. Temporal WMH burden predicts decline in verbal memory. WMH may serve as a surrogate marker for the effect of VRFs on cognitive abilities in PD.

摘要

背景与目的

帕金森病(PD)患者常伴有痴呆,且该疾病具有致残性。因此,明确其可改变的风险因素至关重要。血管危险因素(VRFs)可能与早期 PD 患者的认知能力下降有关。目前,我们需要寻找生物标志物来替代 VRFs 对 PD 产生的长期影响。为此,我们旨在量化早期 PD 患者的脑白质高信号(WMH),并评估其与 VRFs 的相关性,以及与纵向认知的关系。

方法

本研究纳入了帕金森进展标志物倡议研究(PD 患者 141 例,健康对照 63 例)中的参与者,这些参与者均具有充分的基线结构脑磁共振成像数据。我们通过将高血压和糖尿病病史以及体重指数结合起来,创建了一个血管风险评分。通过自动方法对 WMH 进行量化。我们每年使用全面的测试套件评估认知能力。

结果

在 PD 组中,血管风险评分与全脑(β=0.210;P=0.021)、总白质(β=0.214;P=0.013)、额(β=0.220;P=0.002)和颞(β=0.212;P=0.002)区的 WMH 相关。血管风险评分较高的患者其全球认知年度变化率更大(β=-0.040;P=0.007),WMH 年度变化率也更大(β=-0.029;P=0.049)。较高的颞叶 WMH 负担与语言记忆随时间的显著下降有关(β=-0.034;P=0.031)。

结论

在早期 PD 中,可改变的 VRFs 与脑磁共振成像上的 WMH 有关。颞叶 WMH 负担预测语言记忆的衰退。WMH 可能是 VRFs 对 PD 患者认知能力影响的替代标志物。

相似文献

1
Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.可改变的血管危险因素、脑白质病变与早期帕金森病患者的认知功能
Eur J Neurol. 2019 Feb;26(2):246-e18. doi: 10.1111/ene.13797. Epub 2018 Oct 28.
2
White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.脑白质高信号与早期帕金森病认知下降无关——DeNoPa 队列研究。
Parkinsonism Relat Disord. 2019 Dec;69:61-67. doi: 10.1016/j.parkreldis.2019.10.016. Epub 2019 Oct 19.
3
The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.脑白质高信号负担是帕金森病患者进行性轻度认知障碍的预测指标。
Eur J Neurol. 2014 Jun;21(6):922-e50. doi: 10.1111/ene.12412. Epub 2014 Mar 24.
4
Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.横断面和纵向研究帕金森病患者全脑和局部脑白质高信号体积与认知和运动功能的相关性。
Neuroimage Clin. 2019;23:101870. doi: 10.1016/j.nicl.2019.101870. Epub 2019 May 23.
5
Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.根据认知状态,帕金森病患者胆碱能通路的皮质下脑白质高信号。
J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):315-21. doi: 10.1136/jnnp-2011-300872. Epub 2012 Jan 6.
6
Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.嗅觉障碍和白质高信号对帕金森病认知功能的影响。
Parkinsonism Relat Disord. 2016 Mar;24:95-9. doi: 10.1016/j.parkreldis.2015.12.017. Epub 2015 Dec 31.
7
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.白质高信号负荷可预测帕金森病的认知功能衰退,但不能预测运动功能衰退:来自安大略神经退行性疾病研究计划的结果
Eur J Neurol. 2023 Apr;30(4):920-933. doi: 10.1111/ene.15692. Epub 2023 Feb 14.
8
White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.脑白质高信号与新发帕金森病患者未来认知能力下降有关。
Neuroimage Clin. 2018;20:892-900. doi: 10.1016/j.nicl.2018.09.025. Epub 2018 Sep 27.
9
White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.帕金森病中的白质高信号与轻度认知障碍
J Neuroimaging. 2015 Sep-Oct;25(5):754-60. doi: 10.1111/jon.12230. Epub 2015 Mar 5.
10
Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.糖尿病对帕金森病纵向萎缩及认知的影响。
J Neurol Sci. 2017 Jun 15;377:122-126. doi: 10.1016/j.jns.2017.04.010. Epub 2017 Apr 11.

引用本文的文献

1
Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence.合并症及其对帕金森病的影响:当前证据的叙述性概述
Int J Mol Sci. 2025 Mar 24;26(7):2942. doi: 10.3390/ijms26072942.
2
Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain Stimulation.帕金森病与脑深部电刺激患者的白质脑病
Mov Disord Clin Pract. 2025 Mar;12(3):340-345. doi: 10.1002/mdc3.14294. Epub 2024 Dec 4.
3
White matter lesions contribute to motor and non-motor disorders in Parkinson's disease: a critical review.

本文引用的文献

1
Dementia prevention, intervention, and care.痴呆症的预防、干预与护理。
Lancet. 2017 Dec 16;390(10113):2673-2734. doi: 10.1016/S0140-6736(17)31363-6. Epub 2017 Jul 20.
2
Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.阿尔茨海默病中的顶叶白质病变与皮质神经退行性病变相关,但与小血管疾病无关。
Acta Neuropathol. 2017 Sep;134(3):459-473. doi: 10.1007/s00401-017-1738-2. Epub 2017 Jun 21.
3
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.
白质病变在帕金森病中导致运动和非运动障碍:一项批判性综述。
Geroscience. 2025 Feb;47(1):591-609. doi: 10.1007/s11357-024-01428-1. Epub 2024 Nov 22.
4
Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).帕金森病中的心血管自主神经功能障碍与认知障碍(综述)
Med Int (Lond). 2024 Sep 19;4(6):70. doi: 10.3892/mi.2024.194. eCollection 2024 Nov-Dec.
5
Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms.帕金森病合并症的患病率:对预后、诊断的影响及对常见致病机制的见解
J Parkinsons Dis. 2024;14(1):35-52. doi: 10.3233/JPD-230154.
6
Original research: initial development of a pragmatic tool to estimate cognitive decline risk focusing on potentially modifiable factors in Parkinson's disease.原创研究:开发一种实用工具,以估计帕金森病认知衰退风险,重点关注潜在可改变因素。
Front Neurosci. 2023 Oct 24;17:1278817. doi: 10.3389/fnins.2023.1278817. eCollection 2023.
7
Altered sleep and neurovascular dysfunction in alpha-synucleinopathies: the perfect storm for glymphatic failure.α-突触核蛋白病中的睡眠改变与神经血管功能障碍:脑淋巴系统功能衰竭的完美风暴。
Front Aging Neurosci. 2023 Aug 24;15:1251755. doi: 10.3389/fnagi.2023.1251755. eCollection 2023.
8
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study.多巴胺系统对帕金森病长期认知障碍的影响:一项探索性研究。
Mov Disord Clin Pract. 2023 Apr 25;10(6):943-955. doi: 10.1002/mdc3.13751. eCollection 2023 Jun.
9
Lifestyle Modulators of Neuroplasticity in Parkinson's Disease: Evidence in Human Neuroimaging Studies.帕金森病神经可塑性的生活方式调节剂:人类神经影像学研究的证据。
CNS Neurol Disord Drug Targets. 2024;23(5):602-613. doi: 10.2174/1871527322666230616121213.
10
Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease.帕金森病患者的脑血流反应性降低和延迟。
Mov Disord. 2023 Jul;38(7):1262-1272. doi: 10.1002/mds.29429. Epub 2023 May 8.
前瞻性随访的新发帕金森病认知障碍的多模态生物标志物预测
PLoS One. 2017 May 17;12(5):e0175674. doi: 10.1371/journal.pone.0175674. eCollection 2017.
4
The influence of vascular risk factors on cognitive function in early Parkinson's disease.血管危险因素对早期帕金森病认知功能的影响。
Int J Geriatr Psychiatry. 2018 Feb;33(2):288-297. doi: 10.1002/gps.4735. Epub 2017 May 16.
5
Aerobic exercise and vascular cognitive impairment: A randomized controlled trial.有氧运动与血管性认知障碍:一项随机对照试验。
Neurology. 2016 Nov 15;87(20):2082-2090. doi: 10.1212/WNL.0000000000003332. Epub 2016 Oct 19.
6
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease.早期帕金森病中血管疾病及血管危险因素与运动特征和认知的关系
Mov Disord. 2016 Oct;31(10):1518-1526. doi: 10.1002/mds.26698.
7
The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's Disease.帕金森病认知障碍和痴呆的遗传基础
Front Psychiatry. 2016 May 20;7:89. doi: 10.3389/fpsyt.2016.00089. eCollection 2016.
8
Vascular Risk Factors and Cognition in Parkinson's Disease.帕金森病中的血管危险因素与认知
J Alzheimers Dis. 2016;51(2):563-70. doi: 10.3233/JAD-150610.
9
MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection.MUSE:利用配准算法和参数集合以及局部最优图谱选择的多图谱区域分割
Neuroimage. 2016 Feb 15;127:186-195. doi: 10.1016/j.neuroimage.2015.11.073. Epub 2015 Dec 8.
10
The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.白质病变对帕金森病运动和步态症状的影响:文献综述
J Neural Transm (Vienna). 2016 Mar;123(3):241-50. doi: 10.1007/s00702-015-1470-9. Epub 2015 Oct 19.